A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases
- 1 October 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Proteomics
- Vol. 75 (18), 5888-5897
- https://doi.org/10.1016/j.jprot.2012.07.024
Abstract
No abstract availableKeywords
Funding Information
- FP7-PEOPLE-2009-IAPP program (GA 251368)
- EuroKUP COST Action (BM0702)
- eu (HEALTH–F2–2009–241544)
- MRC (G1000791)
This publication has 30 references indexed in Scilit:
- Evaluation of Urinary Biomarkers for Coronary Artery Disease, Diabetes, and Diabetic Kidney DiseaseDiabetes Technology & Therapeutics, 2009
- Capillary electrophoresis–mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: An update of recent developmentsMass Spectrometry Reviews, 2008
- Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialThe Lancet, 2008
- All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in TaiwanThe Lancet, 2008
- Urinary Proteomics in Diabetes and CKDJournal of the American Society of Nephrology, 2008
- Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global OutcomesKidney International, 2007
- Advances in Urinary Proteome Analysis and Biomarker DiscoveryJournal of the American Society of Nephrology, 2007
- Combined Top-Down and Bottom-Up Mass Spectrometric Approach to Characterization of Biomarkers for Renal DiseaseAnalytical Chemistry, 2005
- Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposesKidney International, 2004
- Progression, remission, regression of chronic renal diseasesThe Lancet, 2001